Elizabeth Barnes, PA-C | |
3611 Socialville-foster Rd, Suite 101, Mason, OH 45040 | |
(513) 454-7246 | |
(513) 438-0202 |
Full Name | Elizabeth Barnes |
---|---|
Gender | Female |
Speciality | Physician Assistant |
Location | 3611 Socialville-foster Rd, Mason, Ohio |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1205220696 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208VP0000X | Pain Medicine - Pain Medicine | 50004309 (Ohio) | Secondary |
363A00000X | Physician Assistant | 004309 (Ohio) | Primary |
Mailing Address | Practice Location Address |
---|---|
Elizabeth Barnes, PA-C 3611 Socialville-foster Rd, Suite 101, Mason, OH 45040 Ph: (513) 454-7246 | Elizabeth Barnes, PA-C 3611 Socialville-foster Rd, Suite 101, Mason, OH 45040 Ph: (513) 454-7246 |
News Archive
A new study has shown that eating vegetable nitrates, found mainly in green leafy vegetables and beetroot, could help reduce your risk of developing early-stage age-related macular degeneration.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system (CNS) disorders, today announced the presentation of data from the Phase II -019 Study of pimavanserin in Alzheimer's disease psychosis at the 10th Clinical Trials on Alzheimer's Disease meeting in Boston.
Chemical engineering researchers from Brigham Young University have developed an advanced model that can help predict pollution caused by wildfire smoke.
Genentech, Inc. today announced that a Phase III study (RIBBON 2) of Avastin (bevacizumab) in combination with chemotherapy increased the time women with metastatic HER2-negative breast cancer whose initial chemotherapy had stopped working lived without the disease worsening (progression-free survival or PFS), compared to chemotherapy alone.
Stress in early life may change the immune response in the kidneys, increasing the risk of heart disease later in life, according to a new study. The paper, published ahead of print in the American Journal of Physiology- Renal Physiology, was chosen as an APSselect article for December.
› Verified 4 days ago